Expression of the two sarcomeric actins, a-skeletal and a-cardiac, is regulated in the rodent heart in response to developmental, hormonal, and hemodynamic stimuli. Little is known in man, except that both isogenes were found to be coexpressed in three adult ventricles. In this report, we investigated the isoactin mRNA composition in ventricles from 21 control patients (4 fetal, 5 juvenile, 12 adult) and from 15 patients undergoing cardiac transplantation (5 idiopathic dilated cardiomyopathies, 5 ischemic myopathies with myocardial infarcts, 5 diverse etiologies) by two different and complementary techniques: RNA dot blot analysis with specific cDNA probes, and primer extensions with an oligonucleotide common to a-cardiac and a-skeletal actins. In the case of dot blot analysis, quantification of each isoform was performed by using as standards RNA transcripts obtained from cloned human a-actin sequences, and the total amount of sarcomeric actin mRNA was evaluated as a function oftotal poly (A') RNA. We found that both isogenes are always coexpressed, and that the isoactin pattern changes during development. In utero and in neonatal hearts, a-skeletal actin mRNA represents < 20% of sarcomeric actins, it increases to 48±6% during the first decade after birth and becomes the predominant isoform of adult hearts (60.4±8.5%). The 15 adult failing hearts exhibited the same isoactin pattern as the control ones (62.84±11.06%), and there was no difference in expression between patients with dilated cardiomyopathy or ischemic heart disease. These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the skeletal actin gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the actin and myosin heavy chain families are independently regulated in human heart. (J. Clin. Invest. 1991. 88:323-330.) Key words: skeletal, and cardiac actin mRNAsprimer extension assay * dot blot analysis -fetal, neonatal, adult human hearts * end-stage heart failure
Sarcomeric actins are major components of the thin filaments of striated muscle, and it is the regulated interactions of actins by tropomyosin and the troponin complex with myosins ofthe thick filament which are responsible for contraction and the generation of force. Changes in any of these interactions by intracellular events or changes in the expression ofthe contractile element genes can potentially lead to profound changes in the contractile properties of cardiac muscle. Until now, most attention has been focused on the striking diversity in the pattern of expression for myosin heavy chain isogenes, but the multigene families encoding the other contractile proteins, and more specifically actin, have been studied to a lesser extent (reviews in references 1 and 2).
Two sarcomeric actins, a-cardiac and a-skeletal, are the preponderant actin isoforms detected in the striated muscle of mammals and birds (review in reference 3). These two isoforms are encoded by different genes, and as expected for any protein with such an important role in the function of striated muscle cells, the nucleic acid sequence is highly conserved. These two isoactins, however, differ markedly in the 5' and 3' untranslated regions of the RNA, and by four amino acids at the protein level two ofwhich are located at the amino terminus, the region of the molecule that interacts with myosin during contraction. The amount ofthe isoforms and the respective mRNAs present varies with species, muscle type, development, and aging. In the rat, a-skeletal actin mRNAs account for as much as 50% of the total at birth that rapidly decreases to levels of < 10% in the adult (4) (5) (6) (7) . After the imposition of a chronic hemodynamic overload (5, 8, 9) or the injection of thyroid hormone (10) , a-skeletal actin mRNAs rapidly accumulate in rat ventricles and in the case ofoverload the accumulation is transient (5, 8) . In cultured neonatal cardiomyocytes, a-skeletal actin mRNAs accumulate after the administration of a 1 -adrenergic agonists (6) or growth factors TGF# 1 and bFGF (11) .
In human hearts, much less is known concerning the amounts of the actin mRNAs present during development, with age, or in disease states. Gunning et al. (12) reported that the amount of a-skeletal and a-cardiac actin mRNAs were nearly identical in the heart of a patient suffering from hypertrophic obstructive cardiomyopathy, and Bennetts et al. (13) reported that a-skeletal actin represented -20% of the total a-actin RNA in a patient who died from fatal head injuries and who had no apparent cardiovascular disease. In spite of the difficulty in differentiating between the a-actin isoforms at the protein level, Vandekerckove et al. (3) showed that the skeletal isoform represented 20% of the total in one adult male who died in an automobile accident and in one patient with hypertrophic obstructive cardiomyopathy. It remains therefore un-clear whether or not cardiovascular diseases in man are accompanied by isoactin switches. It is also completely unknown whether there is gene switching with development in human hearts as has been seen in rodents.
We have undertaken the present study using a large set of normal and diseased human hearts to determine ifthe accumulations of the a-actin isomRNAs are regulated in man during development, with aging, and with disease. We hypothesized, because ofcomparisons with the reexpression ofa fetal phenotype in rat cardiac hypertrophy (reviews in references 1 and 2), that a-actin mRNAs would be developmentally regulated and that the isoform predominant during the fetal stage would be up regulated with disease. To address these questions, the sarcomeric isoactin mRNA composition ofhuman hearts was analyzed by two different types of assays, dot blots with specific cDNA probes and primer extensions with an oligonucleotide common to cardiac and skeletal a-actins. Furthermore, the amounts of each isomRNA were quantitated by using as standards RNA transcripts derived from cloned human a-actin sequences, and the total amount of sarcomeric actin mRNA was evaluated as a function of total poly (A') RNA. Our results indicate that the a-actin mRNA accumulations are developmentally regulated, but that they remain essentially constant in normal and failing adult human hearts. 
Methods
Patients. Hearts from four fetuses (13, 17, 18 , and 29 wk in utero), five children aged 3 mo to 12 yr, 12 patients with no apparent cardiovascular problems, and 15 patients with chronic end-stage heart failure were investigated. The 12 control hearts were obtained from the Soviet Union (n = 4), the United States (n = 7), and France (n = 1). Hearts from the Soviet Union came from accident victims and were removed between 0.5 and 3.0 h after the accident. The control patients from the United States and France included children who died from noncardiovascular related diseases and accident victims who were kept under intensive care as potential heart donors but were ultimately rejected for transplantation. The main characteristics ofthese patients are listed in Table I . The 15 failing hearts came from patients that underwent cardiac transplantation, and pertinent characteristics are presented in Table II. Most ofthe patients had already been analyzed forthe amount of cardiac mRNAs encoding the sarcoplasmic reticulum ATPase and were therefore labeled as in the previous study (14) . Left ventricular samples were taken from each heart, and when possible, from different regions ofthe left ventricular free wall (apex, middle, and base). Biopsy samples were also obtained from the liver and abdominal skeletal muscles ofpatients undergoing routine abdominal operative procedures for use as controls in the respective experiments. All samples were obtained under conditions approved by the committees for the protection of human subjects at the respective institutions. Immediately after sampling, the tissues were rinsed, blotted dry, frozen in liquid nitrogen, and stored at -70'C until needed for the preparation of RNA. RNA preparations. Total cardiac, skeletal, and liver RNAs were prepared by the method of Chirgwin et al. (15) by guanidine isothiocyanate extraction, cesium chloride gradient sedimentation, and two consecutive ethanol precipitations in the presence of sodium or potassium acetate. The RNA concentration was determined using standard spectrophotometric techniques. One absorbancy unit at 260 nm in a 1-cm light path cuvette was assumed to be equal to 40 ug/ml of RNA. The RNA was stored at -20'C as a suspension in 70% ethanol containing 0.3 M potassium acetate at pH 5.5.
RNA (dot) blots and quantification oftotal sarcomeric a-actin and poly (A')from human hearts. Dot blots of total human cardiac RNAs were prepared by denaturing total RNA at 650C in 15 X SSC (1 X SSC 17 1-bp fragment in pBR322) specific cDNAs kindly provided by P. Gunning (16) . After subcloning the insert of pLK300 into pGEM3 (pGLK300) and linearizing the plasmids by appropriate enzymatic digestion, RNA transcripts were obtained by promoter driven transcription using the endogenous T7 and SP6 promoters found in each plasmid, pG78 and pGLK300, respectively. Negative controls, transcripts identical to the a-actin human RNAs, were prepared in exactly the same manner, except that the complementary promoter was used, i.e., SP6 for pG78 and T7 for pGLK300. All these transcripts were prepared using the SP6/T7 Transcription Kit (Boehringer-Mannheim, Inc., Indianapolis, IN), and the amount ofRNA was determined by UV absorbance, as described above for total RNA. Serial dilutions of RNA containing both the bacterial promoter generated transcripts (1.5-0.012 fmol) and tRNA sufficient to equal the amount of total human RNA deposed on the membrane were applied to the Hybond membranes in parallel with the human total RNA. The radioactive probes for the two actins (-1.5 X 109 dpm/Ag) were prepared from pG78 and pLK300. control for the amount of RNA effectively bound to the filter from which the actin and poly (A') contents could be normalized, the dehybridized membranes were rehybridized to a T4 polynucleotide kinase -y32P 5' end labeled 18S oligonucleotide probe (17) diluted with unlabeled oligonucleotide to sp act 1.6 X 106 dpm/ug. Hybridization and washing conditions of the two oligonucleotides were as described before (14) . After each hybridization, the membranes were exposed to Cronex 4 film (DuPont Co., Wilmington, DE) using Quanta III intensifying screens (DuPont Co.) at -70°C and at least three different exposure times were chosen to obtain densitometric scans (Shimadzu dualwavelength flying-spot scanner CS-9000) in the linear response range of the x-ray film (semilogarithmic plot). The concentration of each isoactin mRNA was calculated by comparisons with the signals obtained with the plasmid-derived RNAs and was expressed in femtomoles either per 1 Mg oftotal RNA or per 1 arbitrary unit oftotal poly (A+) RNA. One arbitrary unit oftotal poly (A+) RNA was the intensity of the signal given by 1 Mg of liver total RNA. All values were normalized to the amount of 18S RNA bound to the filter. Determination ofthe respective amounts ofa-skeletaland a-cardiac mRNAs by primer extension analyses. The relative proportions of human skeletal and cardiac a-actins were measured simultaneously in the same sample of RNA using a primer extension assay. This technique takes advantage of the differences in length of the 5' noncoding region of each a-actin mRNA and had previously been used to analyze the a-actin mRNAs in the rat (6, 10, 18) . We used an 18 nucleotide primer with the sequence 5'CG GCC CAC GAT GGA CGG G3'. This sequence is conserved between the two human sarcomeric actin genes and corresponds to sequences coding for amino acids 31-37 for both human a-skeletal (19) and human a-cardiac actin (20) . The oligomer was synthesized at the Pasteur Institute, purified from a 20% polyacrylamide gel, and labeled at the 5' end with y32P using the T4 polynucleotide kinase (Boehringer Mannheim, Inc.). 1 pmol of the purified and labeled primer was then added to 8 or 10 Mg of total RNA in the reverse transcriptase reaction (M-MLV reverse transcriptase, Bethesda Research Laboratories, Bethesda, MD) and incubated exactly as described (10) . The precipitated and denatured (90% formamide) reaction products were separated on a 6% denaturing polyacrylamide/urea gel (90 W for 2-3 h) along with a negative (total human liver RNA) and a positive (total human skeletal muscle RNA) control. Most RNAs were analyzed several times on different gels to ensure the reproducibility of the results. The relative position of the two transcribed fragments and the specificity ofthe method are shown in Fig. 1 . With skeletal muscle (Sk), one distinct signal is seen between molecular weight markers of 194 and 234 nucleotides which corresponds well with the predicted value of 222 nucleotides for human a-skeletal actin mRNA. From cardiac muscle (C), two signals are seen, one ofwhich migrates exactly at the same position as that seen with skeletal muscle and a second reverse transcript migrates somewhat faster than the 194 nucleotide marker and corresponds to the predicted length of 174 nucleotides forhuman a-cardiac actin. In some experiments, a second signal which migrated slightly more quickly than the 222 nucleotide signal could be seen on the autoradiograms. By analysis with duplicate samples on the same gel or from other gels which showed only a single band of222 nucleotides, it was determined that the more rapidly migrating band was also transcribed from a-skeletal actin mRNAs; therefore, when these two bands were present, the signals were totaled and the sum of the two was included in all further calculations. It is conceivable that this second band of -218-220 nucleotides resulted from the occasional premature termination by the reverse transcriptase on a-skeletal actin mRNAs. There were no other major bands seen on these autoradiograms. The primer did not hybridize with RNA from the liver (L) indicating that the 174 and 222 nucleotide bands are derived from sarcomeric a-actins. We also verified that smooth muscle actin mRNAs did not interfere with the interpretation of these results. For this, two adult cardiac RNAs were primer extended with two human 18 mer oligonucleotides complementary either to smooth muscle a-actin (5"CG TCC CAC AAT GGA TGG G3) (21, 22) or to smooth muscle y-actin (5'CG GCC CAC AAT GGA GGG G3) (23) . These oligonucleotides differ by three and two bases, respectively, from those used in the primer extension analysis of sarcomeric actins, and correspond to amino acids 31-37 for both human smooth muscle a-and y-actins (21) (22) (23) . No other sequences were identified in these genes that more closely matched the 18 nucleotide primer conserved between the human sarcomeric actin genes. After primer extension with these smooth actin primers, no products corresponding to 222 or 174 nucleotides were seen in these assays (not shown), indicating that the extended products are derived only from striated muscle actins (see Fig. 1 ).
Reproducibility of the procedure (24) based on 16 pairs of duplicates, was ±11% (for, example, a ratio of 60, ranges from 66.6 to 53.4).
Assessment ofactin iso-mRNAs by comparison ofRNA hybridizations andprimer extensions. In one series ofexperiments, skeletal muscle and cardiac muscle RNAs were simultaneously added in inversely proportional amounts of 0, 25, 50, 75, or 100% while maintaining a constant total amount of RNA. The percentage of the a-actins from these RNA mixes was then determined by dot blot hybridization and by primer extension analysis as described. Fig. 2 shows the curves obtained by comparing the determined skeletal/sarcomeric actin mRNA with the theoretical ratio calculated from the value found in the 100% cardiac muscle RNA sample. As can be seen, both techniques show a linear accumulation of a-skeletal actin transcripts with increasing amounts of skeletal muscle RNAs. This result implies that in samples with different concentrations of a-actin isomRNAs both techniques can be used accurately to determine the percentage of these mRNAs in each sample. Based on these results, the majority of the human RNA Sarcomeric Actins in the Developing and Failing Human Heart 325 A products generated by primer extension are shown in the columns labeled L, Sk, and C (liver, skeletal muscle, and cardiac muscle, respectively). There was no signal generated from liver RNAs. In adult skeletal muscle, only one product is detected which has a length of 222 bases. From cardiac muscle two products are detected. One corresponds to a-skeletal actin and a second shorter extension product to a-cardiac actin (174 bases). No other major extension products were observed from the gels. samples were analyzed by primer extension analysis because the percentage of the two actin isomRNAs could be determined simultaneously.
Data analysis. The results are expressed as mean±SD. Statistical evaluations were performed by Student's t test for paired observations, by two-way analysis of variance, and two-sample t test for group to group comparisons, and one-way analysis of variance for comparisons between fetal and adult hearts. The threshold of significance was chosen as values of P < 0.05.
Results
Skeletal and total a-actin accumulate during development. To determine whether there is developmental regulation ofa-actin isomRNA accumulations, the percentage of sarcomeric a-ac- tins in ventricles was quantitated with dot blots using plasmid derived human actin RNAs as references and by primer extension. Fig. 3 shows the comparisons between fetal and adult ventricle sarcomeric actin expression (FH4, 29 wk in utero, and
Ii, 48 yr). In dot blot analysis (Fig. 3 A) , the a-skeletal probe hybridized strongly with its homologous muscle control (adult skeletal muscle, Sk) and its antisense cRNA (+RNA,); (25) . The absolute amounts for FH4 (a-skel < 0.03 and a-card = 0.10 fmol/Ag of total RNA) and for Il (a-skel = 0.64 and a-card = 0.61 fmol/,g of total RNA) indicated that the ratio skeletal/sarcomeric actin mRNA increases from 20 to 51%. The corresponding primer extension analysis (Fig. 3 B) also showed an increased intensity of the a-skeletal band as compared to the a-cardiac one, the ratio increasing from 18 to 62%. Thus, the same conclusions could be drawn by both techniques, i.e., the ventricular isoactin mRNA pattern of expression changes from the fetal to the adult stage.
The complete results obtained in this study are presented in Fig. 4 . Actin a-skeletal mRNA is a minor component of the fetal ventricles (mean value 16.0±3.8%) and does not change markedly just after birth (23%). It increases during the first decade of life (mean value 48.0±6.1%), and by 12 yr of age a drastic reversal ofthe pattern is apparent. At this time, a-skeletal actin becomes the most abundant form (73%), and remains so in adult hearts (60.4±8.5%). The change between 3 mo and 12 yr was confirmed by both techniques (30 and 73%, respectively, by dot blot vs. 23 and 73% by primer extension). Our mean value of 60.4% in the control adult hearts is consistent with that previously reported in one control heart (50%; reference 12), but it is markedly higher than the 20% determined by 326 Boheler, Carrier heart. We found no value of skeletal actin lower than 47% in any of our adult controls.
The use of skeletal and cardiac probes of identical specific activities and the addition of bacterial promoter generated actin sequences to the dot blots allowed us to determine the relative amount of total sarcomeric actin present in the various samples as a function of total poly (A') RNA (Table III) . We observed that total sarcomeric a-actin mRNAs increase between the 29th wk of gestation and after birth relative to poly (A'). This ratio apparently remains stable throughout the first 12 yr of life. In the adult, there is a further increase in a-actins to poly (A') when compared with the ratios obtained in the juvenile and adult hearts. These data strongly suggest that the accumulations of actins are specific events independent of the basal activity of overall mRNA transcription. We also determined the amount ofsarcomeric actin mRNA in adult skeletal muscle and we found that skeletal muscle contains -2.8-fold more sarcomeric actin per microgram of RNA than cardiac muscle (compare C12 and skeletal muscle in Table III ). This is in extremely good agreement with the value of 2.3 previously reported by Gunning et al. (12) . Further studies on RNAs isolated from the adult hearts were performed to determine ifthere were any possible sample differences due to delays in sampling time because ofthe differences in life support in the countries from which the samples were obtained. We were unable to demonstrate any significant differences between the amounts of skeletal actin RNAs in adult hearts of Russian (55.9+9.9%, n = 4), French (62%, n = 1), or American (62.7±7.9%, n = 7) patients. This lack of difference between the pooled groups suggests that variations in life support did not contribute or bias the results obtained in this study.
Heart failure. Cardiac tissue samples were obtained from 15 patients undergoing cardiac transplantation due to advanced stages of heart failure and analyzed. The percentage of a-skeletal actin mRNA to sarcomeric actin mRNA from all pathologic hearts was 62.8±1 1.1%, which is consistent with the 50% value reported for one failing heart (12) . This vs. 53%±9). Additionally, we saw no evidence ofdifferences in the relative amounts of the two sarcomeric a-actins between patients with dilated cardiomyopathy, ischemic heart disease, or any of the other cardiac abnormalities (Fig. 5) . Thus, we conclude that a-actin mRNA accumulations do not change from the normal state with end-stage heart failure.
Discussion
The results presented here confirm that the two sarcomeric a-actin transcripts are coexpressed in the human heart. It is further demonstratedthattheiraccumulations are developmentally regulated, and that the proportion of the transcripts are maintained at a relatively constant level in both the normal and failing adult human ventricles. . Human skeletal actin mRNA accumulations with heart failure are not different from those of normal hearts. Relative sarcomeric actin contents were determined by primer extension from control (N) and diseased human hearts. Results are presented as the percentage of skeletal actin mRNA to sarcomeric actin mRNA ±SD. Diseased human hearts were from patients with ischemic heart disease (I), idiopathic cardiomyopathy (D), and other miscellaneous (Mis) heart ailments (see Table II for the corresponding diseases).
Because ofthe inherent difficulties in precisely quantitating the results of RNA dot blots from different probes, the a-actin mRNA accumulations were studied by two independent and complementary techniques, dot blots and primer extension. Both techniques yielded extremely comparable results, and we chose to study the relative proportions of the actins by primer extension in a majority of the control and failing human heart samples. This technique has the distinct advantage of indicating the proportion ofthe two sarcomeric actins from each RNA preparation simultaneously and unambiguously, and is therefore theoretically more accurate than dot blot analyses (18) . It requires, however, undegraded RNAs, which is often a problem when dealing with human cardiac samples but was not for our samples because of rapid collection and careful storage. Indeed, all the RNAs that we used yielded two predominant bands corresponding to a-skeletal and a-cardiac actins. Moreover, it was previously shown for most of the human RNAs used in this study by Northern blot analysis to myosin heavy chain and Ca"+ ATPase specific cDNAs that they were not degraded (14) . AU this indicated that our experimental conditions allowed precise analysis of the human isoactin mRNA pattern.
The main finding of this study is that cardiac actin mRNA is the major isoform ofthe human fetal heart, whereas skeletal actin predominates in young and adult hearts. This finding is somewhat different from that found in other animal species, although both types of actin have been shown to be coexpressed at all stages of animal development thus far examined. In chick heart, transcripts for both actins accumulate at similar levels as early as 2.5 d in ovo, but in adults, the cardiac form predominates substantially over the skeletal actin mRNA (18) . In mouse, cardiac actin is detectable in the primitive heart tube slightly earlier than the skeletal one (7.5 d vs. 7.8 d postcoitum), and the skeletal actin transcripts are always much lower than those of cardiac actin (at least 25-fold less when estimated by the respective grain densities from in situ hybridization experiments) (26) . Skeletal actin is hardly detectable in adult mouse heart (27) . In the hearts of late fetal and newborn rats, the mRNAs for both actins are present in almost equivalent amounts but cardiac actin is almost unique in adult animals (4-10). Man, therefore, is the only species so far studied in which skeletal actin mRNA increases in the heart after birth and accumulates at higher levels than cardiac actin mRNA in adults. 328 Boheler, Carrier (3) . Although elegant, this technique is delicate and difficult to perform. Using this technique, only two human hearts, one control and one pathologic, were analyzed by the authors. The ventricles and one atrium were reported to contain -20% skeletal isoactin, which corresponds well with the ventricular mRNA percentage found by Bennetts from another human adult heart (13). It would, however, be hazardous to propose from this sole analysis that isoprotein composition reflects isomRNA composition. Our results show variability from one heart to the other (see Fig. 4 ), and only a precise comparison ofthe protein and mRNA levels on the same heart would allow one to draw such a conclusion. For other large mammals, the situation appears analagous to that seen in man at the protein level. Skeletal isoactins account for 20% of the total actin protein in adult bovine and porcine hearts (3); however, the percentages ofthe mRNAs are currently unknown. It has been recently suggested that during terminal differentiation of skeletal muscle cells in vitro, RNA accumulations of actin and myosin light chain are regulated at both transcriptional and posttranscriptional levels (28). It is currently not possible to compare on a large series ofhuman hearts, the actin isoprotein and isomRNA composition or to analyze in the human heart either the transcriptional activity ofthe actin genes, or the mRNA stabilities, and perhaps bovine and porcine cardiac cells could be used to address these regulatory questions.
What are the factors that might regulate the developmental changes that we have found in man? The promoter regions of human cardiac and skeletal actin genes have been extensively analyzed. They contain at least five types of upstream regulatory elements and current results indicate that very complex interactions take place between the transcriptional factors in these regions (review in reference 29); however, almost nothing is known concerning the sequences and the factors that interact with these sequences to confer muscle specificity ofexpression and that might be responsible for the up/down regulation of actin genes in cardiac muscle. Our data open further insights into these types of study by providing developmental stages corresponding to different patterns ofexpression. Recent studies have shown that thyroid hormone (10) and peptide growth factors TGF# I and bFGF (1 1) up-regulate the skeletal actin gene in the adult heart and in neonatal cardiac cells, respectively. It would therefore be of further interest to examine the hypothesis that these components participate in the control of actin genes during human cardiac development.
With human heart failure, apparently no transition to a putative fetal actin isoform pattern occurs (Fig. 5) . Skeletal actin transcripts remain the most abundant isomRNA at 62% of total sarcomeric actin. In rat, after a hemodynamic overload, skeletal actin transcripts rapidly and transiently accumulate (5, 8) . The significance of this accumulation is unknown. We are unable to say whether human hearts synthesize an even higher percentage of skeletal actin isomRNAs in earlier stages ofheart disease and therefore cannot rule out similar transitory changes. Our results, however, strongly suggest that the molecular basis of thin filament disregulation during heart failure is not actin.
Finally these results provide evidence ofindependent regulation of the multigene families encoding the two main proteins responsible for human cardiac contraction, myosin heavy chain, and actin. In human ventricles, j3-myosin heavy chain is almost the exclusive form present at all ages, even though the a form seems to increase after birth (30, 31) . One would like to hypothesize that these two sarcomeric proteins would be highly and mutually coordinated at the transcriptional and/or translational levels and that this coordination should in turn lead to the most efficient state ofcontraction under normal and pathological conditions. This, however, does not seem to be the case and further attempts to elucidate the mechanisms of cardiac myogenesis in man will be needed to account for these independent regulations.
